Leadership transition strengthens Redcliffe Labs’ focus on scaling technology-led diagnostics, operational excellence, and preventive healthcare access
Doctors highlight rising respiratory risks linked to pollution, seasonal changes, and poor treatment adherence amid increasing asthma burden in India
Approval expands Lupin’s specialty portfolio in the US market for treatment of urea cycle disorders
Discussions focused on digital health, non-communicable diseases, resilient supply chains, medical innovation, and healthcare workforce development
Company plans to appeal against CGST order related to alleged inadmissible input tax credit claims
Pharma and healthcare stocks stay in focus as investors track earnings, USFDA approvals, hospital growth, and global market pressures
Marking World Asthma Day 2026, doctors sounded the alarm over a steady surge in respiratory illnesses
The ISG assessment highlights Indegene’s deep domain expertise, proprietary technology stack, and expanding use of AI and GenAI to drive more integrated, data-led commercial execution across the life sciences value chain
Keeps Halo Pharma to drive independent growth
The company secured new accounts, including ACCESS-PVI trial sites, and aims to strengthen global commercialization efforts
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
